TIGIT and breast cancer: Moreover, the expression of LAG3, CTLA-4, PD-L1, CD274, TIGIT, HAVCR2 and PDCD1LG2 was upregulated in the TFRC high-expression group compared with the TFRC low-expression group in breast cancer (Chen F. et al., 2021).